InnoCore, Allergan sign license, collaboration agreement

InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan, according to a news release.Under the agreement, the companies will expand their existing collaboration and continue to develop long-acting ocular drug delivery products to treat ophthalmic diseases, the release said.  

Full Story →